FI830378L - Pyrazoloxaziner, -tiaziner, -kinoliner, foerfarande foer deras framstaellning och deras anvaendninglaekemedel - Google Patents

Pyrazoloxaziner, -tiaziner, -kinoliner, foerfarande foer deras framstaellning och deras anvaendninglaekemedel

Info

Publication number
FI830378L
FI830378L FI830378A FI830378A FI830378L FI 830378 L FI830378 L FI 830378L FI 830378 A FI830378 A FI 830378A FI 830378 A FI830378 A FI 830378A FI 830378 L FI830378 L FI 830378L
Authority
FI
Finland
Prior art keywords
deras
tiaziner
pyrazoloxaziner
kinoliner
anvaendninglaekemedel
Prior art date
Application number
FI830378A
Other languages
English (en)
Other versions
FI830378A0 (fi
Inventor
Rudolf Sundermann
Harald Horstmann
Siegfried Raddatz
Mithat Mardin
Wolf-Dieter Busse
Friedrich Hoffmeister
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI830378A0 publication Critical patent/FI830378A0/fi
Publication of FI830378L publication Critical patent/FI830378L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI830378A 1982-02-06 1983-02-03 Pyrazoloxaziner, -tiaziner, -kinoliner, foerfarande foer deras framstaellning och deras anvaendninglaekemedel FI830378L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823204126 DE3204126A1 (de) 1982-02-06 1982-02-06 Pyrazoloxazine, -thiazine, -chinoline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
FI830378A0 FI830378A0 (fi) 1983-02-03
FI830378L true FI830378L (fi) 1983-08-07

Family

ID=6154989

Family Applications (1)

Application Number Title Priority Date Filing Date
FI830378A FI830378L (fi) 1982-02-06 1983-02-03 Pyrazoloxaziner, -tiaziner, -kinoliner, foerfarande foer deras framstaellning och deras anvaendninglaekemedel

Country Status (16)

Country Link
US (1) US4552874A (fi)
EP (1) EP0085881A3 (fi)
JP (1) JPS58146583A (fi)
KR (1) KR840003641A (fi)
AU (1) AU1112583A (fi)
DE (1) DE3204126A1 (fi)
DK (1) DK49283A (fi)
ES (1) ES519559A0 (fi)
FI (1) FI830378L (fi)
GR (1) GR77960B (fi)
HU (1) HU190063B (fi)
IE (1) IE830227L (fi)
IL (1) IL67826A0 (fi)
NO (1) NO830236L (fi)
PT (1) PT76147A (fi)
ZA (1) ZA83743B (fi)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO834401L (no) * 1982-12-14 1984-06-15 Troponwerke Gmbh & Co Kg Pyrazolo(4.3-b)(1.4)oxasiner, fremgangsmaate til deres fremstilling og deres anvendelse som legemiddel
US4749699A (en) * 1983-10-31 1988-06-07 Merck Frosst Canada, Inc. 5-lipoxygenease inhibitors
US4634766A (en) * 1983-10-31 1987-01-06 Merck Frosst Canada, Inc. 1,4-diaza-phenothiazines
ES8602818A1 (es) * 1983-10-31 1985-12-01 Merck Frosst Canada Inc Una composicion farmaceutica
US5756747A (en) * 1989-02-27 1998-05-26 Riker Laboratories, Inc. 1H-imidazo 4,5-c!quinolin-4-amines
US4929624A (en) * 1989-03-23 1990-05-29 Minnesota Mining And Manufacturing Company Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
US5037986A (en) * 1989-03-23 1991-08-06 Minnesota Mining And Manufacturing Company Olefinic 1H-imidazo[4,5-c]quinolin-4-amines
US5116837A (en) * 1990-12-21 1992-05-26 Ortho Pharmaceutical Corporation 2,9-dihydro-(6 or 7)-(3-oxo-2,3,4,5-tetrahydropyridazinyl)-pyrazolo [4,3-B]-1,4-benzoxazines
US5271944A (en) * 1991-04-05 1993-12-21 Biofor, Ltd. Pharmacologically enhanced formulations
DE4122035A1 (de) * 1991-07-03 1993-01-07 Henkel Kgaa Die verwendung von 1,9-dihydro-pyrazolo(4,3-b) (1,4)-benzoxazinen als kuppler fuer oxidationsfaerbemittel
US5608067A (en) * 1993-12-09 1997-03-04 Afonso; Adriano 4-substituted pyrazoloquinoline derivatives
US5786480A (en) * 1994-04-28 1998-07-28 Schering Corporation 4-substituted pyrazoloquinoline derivatives
WO1997021689A1 (fr) * 1995-12-08 1997-06-19 Ube Industries, Ltd. Composes de n-phenylcarbamate, procede de production et bactericides agricoles ou horticoles
EP1653914A4 (en) 2003-08-12 2008-10-29 3M Innovative Properties Co COMPOUNDS CONTAINING OXIME SUBSTITUTED IMIDAZO STRUCTURE
MXPA06002199A (es) 2003-08-27 2006-05-22 3M Innovative Properties Co Imidazoquinolinas sustituidas con grupos ariloxi o arilalquilenoxi.
JP2007504269A (ja) 2003-09-05 2007-03-01 スリーエム イノベイティブ プロパティズ カンパニー Ｃｄ５＋ｂ細胞リンパ腫の治療方法
AU2004278014B2 (en) 2003-10-03 2011-04-28 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
CN1906192A (zh) 2003-11-14 2007-01-31 3M创新有限公司 羟胺取代的咪唑环化合物
EP1685129A4 (en) 2003-11-14 2008-10-22 3M Innovative Properties Co OXIMSUBSTITUTED IMIDAZORING CONNECTIONS
MXPA06005910A (es) 2003-11-25 2006-08-23 3M Innovative Properties Co Sistemas de anillo imidazo sustituido y metodos.
US8802853B2 (en) 2003-12-29 2014-08-12 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
WO2005066169A2 (en) 2003-12-30 2005-07-21 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
US8697873B2 (en) 2004-03-24 2014-04-15 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
WO2005123080A2 (en) 2004-06-15 2005-12-29 3M Innovative Properties Company Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
WO2006038923A2 (en) 2004-06-18 2006-04-13 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
US7915281B2 (en) 2004-06-18 2011-03-29 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
WO2006009826A1 (en) 2004-06-18 2006-01-26 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
JP5543068B2 (ja) 2004-12-30 2014-07-09 スリーエム イノベイティブ プロパティズ カンパニー キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物
CA2594674C (en) 2004-12-30 2016-05-17 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
CA2597092A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune reponse modifiers
WO2006086634A2 (en) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
US7943636B2 (en) 2005-04-01 2011-05-17 3M Innovative Properties Company 1-substituted pyrazolo (3,4-C) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
AU2006232377A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
US7906506B2 (en) 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
WO2008154438A1 (en) * 2007-06-08 2008-12-18 Helicon Therapeutics, Inc. Therapeutic pyrazoloquinoline derivatives
JP2010529144A (ja) * 2007-06-08 2010-08-26 ヘリコン・セラピューティクス・インコーポレーテッド 治療用ピラゾロキノリン尿素誘導体
EP2166853B1 (en) * 2007-06-08 2014-05-28 Dart Neuroscience (Cayman) Ltd Therapeutic pyrazolonaphthyridine derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4891096A (fi) * 1972-03-08 1973-11-27
US3790576A (en) * 1972-03-20 1974-02-05 Parke Davis & Co 9 substituted 4,9-dihydro-1,3,4,4-tetraalkyl-1h-pyrazolo(3,4-b)quinolines

Also Published As

Publication number Publication date
IL67826A0 (en) 1983-06-15
ES8402591A1 (es) 1984-02-01
ES519559A0 (es) 1984-02-01
HU190063B (en) 1986-08-28
JPS58146583A (ja) 1983-09-01
DK49283D0 (da) 1983-02-04
DE3204126A1 (de) 1983-08-11
US4552874A (en) 1985-11-12
AU1112583A (en) 1983-08-11
EP0085881A2 (de) 1983-08-17
GR77960B (fi) 1984-09-25
DK49283A (da) 1983-08-07
EP0085881A3 (de) 1984-03-07
ZA83743B (en) 1983-11-30
FI830378A0 (fi) 1983-02-03
KR840003641A (ko) 1984-09-15
NO830236L (no) 1983-08-08
IE830227L (en) 1983-08-06
PT76147A (en) 1983-02-01

Similar Documents

Publication Publication Date Title
FI830752L (fi) Karboxialkyldipeptider, foerfaranden foer deras framstaellning och farmaceutiska blandningar innehaollande dessa
FI831591A0 (fi) Azolylmetyloxiraner, deras framstaellningsfoerfarande och dessa innehaollande fungicider
FI830378A0 (fi) Pyrazoloxaziner, -tiaziner, -kinoliner, foerfarande foer deras framstaellning och deras anvaendning laekemedel
FI842601A0 (fi) Utdelningsanordning och uppteckningsapparat.
FI834888A0 (fi) Gonadoliberinderivat, foerfarande foer deras framstaellning och farmaceutiska och veterinaermedicinblandningar framstaellda daerav
FI833398A (fi) Termiticidala atraktantfoereningar, kompositioner och foerfarande foer deras anvaendning
FI834430A (fi) Haorfaergningsfoerfarande och faergningskompositionsfoerpackning.
FI834452A (fi) Aromatiska oligomerer och hartser.
FI824126L (fi) Foerfarande i laonghaolbergborrning och borrstaongsystem.
FI833857A (fi) Jaemn och med roterande skiva foersedd trycksil foer en medelkonsistens.
FI830457L (fi) Laosanordning, speciellt foer laemmar till lastflak och dylikt
FI833390A (fi) Utmatningsanordning med bortsvepningsoeppningar och utmatningsfoerfarande.
FI842376A (fi) Monoskopisk och stereoskopisk televisionsapparat.
FI831790A0 (fi) Piperazinderivat, deras framstaellning och dessa innehaollande farmaceutiska foereningar
FI831367L (fi) Pleuromutillinderivat, deras framstaellningsfoerfarande och farmaceutiska anvaendning
FI830297L (fi) Benzotiennylallylaminer, foerfarande foer deras producering och deras anvaendning saosom laekemedel
FI832789A (fi) Mjoeldrygealkaloider, deras framstaellning och anvaendning
FI833292A0 (fi) Piperidinderivat, deras framstaellning och anvaendning
FI833337A0 (fi) Heterocykliska foereningar, deras framstaellning, dessa innehaollande kompositioner och foerfarandekontrollering av ooenskad tillvaext av vaexter
FI833102A0 (fi) Substituerade 1-pyridyloxi-3-indolylalkyl-amino-2-propanoler, deras framstaellning och anvaendning
FI830206L (fi) Roterande, gaengfoersedd borrande och gaengbildande skruv
FI830992L (fi) 7- -aminoacyl-3-klorkefalosporiner, foerfarande foer deras framstaellning och deras anvaendning solaekemedel
FI821506A0 (fi) Saekerhetskoppling foer baotar, motorslaedar och liknande
FI823970A0 (fi) Slaeptaetningsmontering foer foenster och motsvarande oeppningsbara byggnadsdelar, baoge och taetninmontering
FI824193L (fi) Foerfarande och anordning foer torvproduktion.

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: BAYER AKTIENGESELLSCHAFT